Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers

Name: Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers
Published: 2022
License: Public Domain

Benfovir AG · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

pharmacokinetics safety sars-cov-2

healthy volunteers, benfo-oxythiamine (b-ot), oxythiamine, phase i, pharmacokinetics, safety, transketolase inhibitor, sars-cov-2, covid-19, prodrug, thiamine antagonist, metabolic inhibitor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 871931
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.